Full text is available at the source.
Ether bond-modified lipid nanoparticles for enhancing the treatment effect of hepatic fibrosis
Lipid nanoparticles with ether bonds to improve treatment of liver scarring
AI simplified
Abstract
LNP-O1 suppressed HSP47 expression by approximately 84% in fibrosis mice, three times more effective than LNP-M.
- Lipid nanoparticles (LNPs) can deliver RNA for potential liver disease treatments.
- Incorporating an ether bond into ionizable lipids may enhance delivery efficiency.
- Three novel ionizable lipids, ND-O1, ND-O2, and ND-O3, were synthesized for this purpose.
- LNP-O1 showed improved siRNA transfection efficiency in activated fibroblasts compared to LNP-M.
- LNP-O1 led to a significant reduction in collagen deposition and improvement in liver fibrosis.
AI simplified